What these buzzy new tests can and can't tell you.

Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...

Self-collection means swabbing your vagina to get a sample of cells to test in the lab. In this case, the sample is used to ...

It's the top cause of cancer death for men and women combined, a new study says.

The FDA has approved a new at-home test for cervical cancer screening that could make early detection more accessible for ...

Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...

New research shows patients can skip the dreaded colonoscopy without sacrificing protection from colorectal cancer.

The researchers examined the five leading causes of cancer death among the under-50 age group. They found that overall, from 1990 through 2023, more than 1.2 million people died of cancer in the ...

Silent cancers grow quietly with few or vague symptoms, often delaying diagnosis until advanced stages. Cancers of the ...

The disease steadily has been killing more Americans under 50 for years as the mortality rates for other cancers have fallen, ...

Pancreatic cancer is the third leading cause of cancer-related deaths, trailing behind lung cancer and colorectal cancer, a ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...